MedPath

Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy

Active, not recruiting
Conditions
Idiopathic Pulmonary Arterial Hypertension
Registration Number
NCT06587074
Lead Sponsor
Russian Cardiology Research and Production Center
Brief Summary

This study will be performed based on a retrospective analysis of the cases of 150-170 patients with IPAH observed at the Research Institute of Clinical Cardiology over the past 10 years, for a comparative assessment of the survival of groups of patients with IPAH diagnosed in the period 2004-2013 and 2014-2023.

The demographic, clinical, functional, hemodynamic characteristics of patients, comorbidity, blood biomarker levels, received PAH-specific and symptomatic therapy will be assessed in order to determine the clinical characteristics of patients with IPAH.

The prospective part of study will include 50 patients with IPAH.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • age over 18 years;
  • verified diagnosis of IPAH
Exclusion Criteria
  • age under 18 years;
  • Other etiology op PAH,
  • ischemic heart disease confirmed by MSCT of the coronary arteries or coronary angiography;
  • diseases of the musculoskeletal system that prevent 6MWT
  • severe liver dysfunction (more than 9 points on the Child-Pugh scale, class C)
  • severe renal dysfunction (CC less than 15 ml/min), need for hemodialysis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality in 3 years after diagnosed IPAH3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Russian National Cardilogy Reasearch Center

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath